Leukemia Inhibitory Factor Antisense Oligonucleotide Inhibits the Development of Murine Embryos at Preimplantation Stages

Biology of Reproduction

Volumn 70, Issue 5, 2004, Pages 1270-1276

  Cheng, Tzu Chun ^a,b,c   Huang, Chun Chia ^a,c   Chen, Chung I ^c   Liu, Chung Hsien ^d   Hsieh, Yih Shou ^a   Huang, Chih Yang ^a   Lee, Maw Sheng ^b,c,d,e   Liu, Jer Yuh ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c Lee Women's Hospital   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e Lee Women's Hospital   (Taiwan)

Author keywords

Cytokines; Developmental biology; Early development; Embryo; Growth factors

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LEUKEMIA INHIBITORY FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLASTOCYST; BLASTOMERE; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; ECTODERM; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GROWTH INHIBITION; IMMUNOREACTIVITY; INNER CELL MASS; MALE; MICROINJECTION; MORULA; MOUSE; NONHUMAN; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PRONUCLEUS; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE;

ANIMALS; BLASTOCYST; EMBRYO IMPLANTATION; EMBRYONIC DEVELOPMENT; FEMALE; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; MICE; OLIGONUCLEOTIDES, ANTISENSE;

ANIMALIA; ILEX COOKII; MAMMALIA; MURINAE;

EID: 1942508949     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.103.023283     Document Type: Article

References (49)

1. Robb L, Dimitriadis E, Li R, Salamonsen LA. Leukemia inhibitory factor and interleukin-11: cytokines with key roles in implantation. J Reprod Immunol 2002; 57:129-141.
2. Lass A, Weiser W, Munafo A, Loumaye E. Leukemia inhibitory factor in human reproduction. Fertil Steril 2001; 76:1091-1096.
3. Vogiagis D, Salamonsen LA. Review: the role of leukaemia inhibitory factor in the establishment of pregnancy. J Endocrinol 1999; 160:181-190.
4. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359:76-79.
5. Giess R, Tanasescu I, Steck T, Sendtner M. Leukaemia inhibitory factor gene mutations in infertile women. Mol Hum Reprod 1999; 5: 581-586.
6. Jurisicova A, Ben-Chetrit A, Varmuza SL, Casper RF. Recombinant human leukemia inhibitory factor does not enhance in vitro human blastocyst formation. Fertil Steril 1995; 64:999-1002.
7. Sirisathien S, Hernandez-Fonseca HJ, Bosch P, Hollet BR, Lott JD, Brackett BG. Effect of leukemia inhibitory factor on bovine embryos produced in vitro under chemically defined conditions. Theriogenology 2003; 59:1751-1763.
8. Mitchell MH, Swanson RJ, Hodgen GD, Oehninger S. Enhancement of in vitro murine embryo development by recombinant leukemia inhibitory factor. J Soc Gynecol Invest 1994; 1:215-219.
9. Tsai HD, Chang CC, Hsieh YY, Hsu LW, Chang SC, Lo HY. Effect of different concentrations of recombinant leukemia inhibitory factor on different development stage of mouse embryo in vitro. J Assist Reprod Genet 2000; 17:352-355.
10. Marquant-Le GB, Humbolt P, Guillon N, Thibier M. Murine LIF improves the development of IVF cultured bovine morulae. J Reprod Fertil Abstr 1993; 12:61.
11. Dunglison GF, Barlow DH, Sargent IL. Leukaemia inhibitory factor significantly enhances the blastocyst formation rates of human embryos cultured in serum-free medium. Hum Reprod 1996; 11:191-196.
12. Hsieh YY, Tsai HD, Chang CC, Hsu LW, Chang SC, Lo HY. Prolonged culture of human cryopreserved embryos with recombinant human leukemia inhibitory factor. J Assist Reprod Genet 2000; 17: 131-134.
13. Naz RK, Kumar G, Minhas BS. Expression and role of c-myc protooncogene in murine preimplantation embryonic development. J Assist Reprod Genet 1994; 11:208-216.
14. Quinn P. Enhanced results in mouse and human embryo culture using a modified human tubal fluid medium lacking glucose and phosphate. J Assist Reprod Genet 1995; 12:97-105.
15. Hogan B, Beddington R, Costantini F, Lacy E. 1994. Manipulating the Mouse Embryo: A Laboratory Manual, 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1994.
16. Piekos MW, Frasor J, Mack S, Binor Z, Soltes B, Molo MW, Radwanska E, Rawlins RG. Evaluation of co-culture and alternative culture systems for promoting in vitro development of mouse embryos. Hum Reprod 1995; 10:1486-1491.
17. Nagy A, Gertsenstein M, Vintersten K, Behringer R. Manipulating the Mouse Embryo: A Laboratory Manual, 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2003.
18. Cai LQ, Cao YJ, Duan EK. Effects of leukaemia inhibitory factor on embryo implantation in the mouse. Cytokine 2000; 12:1676-1682.
19. Mitchell MH, Swanson RJ, Oehninger S. In vivo effect of leukemia inhibitory factor (LIF) and an anti-LIF polyclonal antibody on murine embryo and fetal development following exposure at the time of transcervical blastocyst transfer. Biol Reprod 2002; 67:460-464.
20. Heasman J. Morpholino oligos: making sense of antisense? Dev Biol 2002; 243:209-214.
21. Paria BC, Dey SK, Andrews GK. Antisense c-myc effects on preimplantation mouse embryo development. Proc Natl Acad Sci U S A 1992; 89:10051-10055.
22. Watson AJ, Westhusin ME, De Sousa PA, Betts DH. Barcroft lethal concentration. Gene expression regulating blastocyst formation. Theriogenology 1999; 1:117-133.
23. Siddall LS, Barcroft LC, Watson AJ. Targeting gene expression in the preimplantation mouse embryo using morpholino antisense oligonucleotides. Mol Reprod Dev 2002; 63:413-421.
24. Kimber WL, Puri N, Borgmeyer C, Ritter D, Sharov A, Seidman M, Ko MS. Efficacy of 2-methoxyethoxy-modified antisense oligonucleotides for the study of mouse preimplantation development. Reprod Biomed Online 2003; 6:318-322.
25. Schultz RM. The molecular foundations of the maternal to zygotic transition in the preimplantation embryo. Hum Reprod Update 2002; 8:323-331.
26. Summerton J, Weller D. Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev 1997; 7:187-195.
27. Zollner U, Zollner KP, Hartl G, Diet J, Steck T. The use of a detailed zygote score after IVF/ICSI to obtain good quality blastocysts: the German experience. Hum Reprod 2002; 17:1327-1333.
28. Liu N, Jin C, Zhu ZM, Zhang J, Tao H, Ge C, Yang S, Zhang S. Stage-specific expression of alpha1, 2-fucosyltransferase and alpha1, 3-fucosyltransferase (FT) during mouse embryogenesis. Eur J Biochem 1999; 265:258-263.
29. Pantaleon M, Harvey MB, Pascoe WS, James DE, Kaye PL. Glucose transporter GLUT3: ontogeny, targeting, and role in the mouse blastocyst. Proc Natl Acad Sci U S A 1997; 94:3795-3800.
30. Terada A, Minoura H, Toyoda N. Effects of epidermal growth factor on preimplantation mouse embryos. J Assist Reprod Genet 1997; 14: 404-411.
31. Fedorcsak P, Storeng R. Effects of leptin and leukemia inhibitory factor on preimplantation development and STAT3 signaling of mouse embryos in vitro. Biol Reprod 2003; 69:1531-1538.
32. Tarin JJ, Gomez-Piquer V, Perez-Albala S, Hermenegildo C, Cano A. Predictive variables of in vitro fertilization and preimplantation embryo development in the mouse. Mol Reprod Dev 2002; 63:38-46.
33. Amano T, Nakamura K, Tani T, Kato Y, Tsunoda Y. Production of mice derived entirely from embryonic stem cells after injecting the cells into heat treated blastocysts. Theriogenology 2000; 53:1449-1458.
34. Machaty Z, Day BN, Prather RS. Development of early porcine embryos in vitro and in vivo. Biol Reprod 1998; 59:451-455.
35. De Hertogh R, Vanderheyden I, Pampfer S, Robin D, Dufrasne E, Delcourt J. Stimulatory and inhibitory effects of glucose and insulin on rat blastocyst development in vitro. Diabetes 1991; 40:641-647.
36. Sjoblom C, Wikland M, Robertson SA. Granulocyte-macrophage colony-stimulating factor promotes human blastocyst development in vitro. Hum Reprod 1999; 14:3069-3076.
37. Wuu YD, Pampfer S, Becquet P, Vanderheyden I, Lee KH, De Hertogh R. Tumor necrosis factor alpha decreases the viability of mouse blastocysts in vitro and in vivo. Biol Reprod 1999; 60:479-483.
38. Cheng TC, Huang CC, Huang LS, Chen CI, Lee Sheng, Liu JY. Evaluation of mouse blastocyst implantation rate by morphology grading. Chin J Physiol 2004; 47:43-47.
39. McElhinny AS, Kadow N, Warner CM. The expression pattern of the Qa-2 antigen in mouse preimplantation embryos and its correlation with the Ped gene phenotype. Mol Hum Reprod 1998; 4:966-971.
40. Kang YK, Park JS, Koo DB, Choi YH, Kim SU, Lee KK, Han YM. Limited demethylation leaves mosaic-type methylation states in cloned bovine preimplantation embryos. EMBO J 2002; 21:1092-1100.
41. Hardy K, Spanos S. Growth factor expression and function in the human and mouse preimplantation embryo. J Endocrinol 2002; 172: 221-236.
42. Lighten AD, Hardy K, Winston RM, Moore GE. Expression of mRNA for the insulin-like growth factors and their receptors in human preimplantation embryos. Mol Reprod Dev 1997; 47:134-139.
43. Spanos S, Becker DL, Winston RM, Hardy K. Anti-apoptotic action of insulin-like growth factor-I during human preimplantation embryo development. Biol of Reprod 2000; 63:1413-1420.
44. Bridsal MA, Hopkisson JF, Grant KE, Barlow DH, Mardon HJ. Expression of heparin-binding epidermal growth factor messenger RNA in the human endometrium. Mol Hum Reprod 1996; 2:31-34.
45. Zhao Y, Chegini N. The expression of granulocyte macrophage-colony stimulating factor (GM-CSF) and receptors in human endometrium. Am J Reprod Immunol 1999; 42:303-311.
46. Martin KL, Barlow DH, Sargent IL. Heparin-binding epidermal growth factor significantly improves human blastocyst development and hatching in serum-free medium. Hum Reprod 1998; 13:1645-1652.
47. Blangy A, Vidal F, Cuzin F, Yang YH, Boulukos K, Rassoulzadegan M. CDEBP, a site-specific DNA-binding protein of the 'APP-like' family, is required during the early development of the mouse. J Cell Sci 1995; 108:675-683.
48. Ye J, Young HA, Ortaldo JR, Ghosh P. Identification of a DNA binding site for the nuclear factor YY1 in the human GM-CSF core promoter. Nucleic Acids Res 1994; 22:5672-5678.
49. Weill L, Shestakova E, Bonnefoy E. Transcription factor YY1 binds to the murine beta interferon promoter and regulates its transcriptional capacity with a dual activator/repressor role. J Virol 2003; 77:2903-2914.